Clinical experience using Delta 4 phantom for pretreatment patient-specific quality assurance in modern radiotherapy

被引:9
|
作者
Srivastava, R. P. [1 ,3 ]
De Wagter, C. [1 ,2 ]
机构
[1] Ghent Univ Hosp, Dept Radiat Oncol, C Heymanslaan 10,Radiotherapiepk, B-9000 Ghent, Belgium
[2] Ghent Univ Hosp, Dept Radiat Oncol & Expt Canc Res, Ghent, Belgium
[3] Ctr Hosp Mouscron, Radiotherapy Assoc Meuse Picardie, Mouscron, Belgium
关键词
gamma index; intensity-modulated radiation therapy; multi-leaf collimator; quality assurance; volumetric-modulated arc therapy;
D O I
10.1017/S1460396918000572
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose In advanced radiotherapy techniques such as intensity-modulated radiation therapy (IMRT), the quality assurance (QA) process is essential. The aim of the study was to assure the treatment planning dose delivered during delivery of complex treatment plans. The QA standard is to perform patient-specific comparisons between planned doses and doses measured in a phantom. Materials and method The Delta 4 phantom (Scandidos, Uppsala, Sweden) has been used in this study. This device consists of diode matrices in two orthogonal planes inserted in a cylindrical acrylic phantom. Each diode is sampled per beam pulse so that the dose distribution can be evaluated on segment-by-segment, beam-by-beam, or as a composite plan from a single set of measurements. Ninety-five simple and complex radiotherapy treatment plans for different pathologies, planned using a treatment planning system (TPS) were delivered to the QA device. The planned and measured dose distributions were then compared and analysed. The gamma index was determined for different pathologies. Results The evaluation was performed in terms of dose deviation, distance to agreement and gamma index passing rate. The measurements were in excellent agreement between with the calculated dose of the TPS and the QA device. Overall, good agreement was observed between measured and calculated doses in most cases with gamma values above 1 in >95% of measured points. Plan results for each test met the recommended dose goals. Conclusion The delivery of IMRT and volumetric-modulated arc therapy (VMAT) plans was verified to correspond well with calculated dose distributions for different pathologies. We found the Delta 4 device is accurate and reproducible. Although Delta4 appears to be a straightforward device for measuring dose and allows measure in real-time dosimetry QA, it is a complex device and careful quality control is required before its use.
引用
收藏
页码:210 / 214
页数:5
相关论文
共 50 条
  • [1] Patient-Specific Quality Assurance Techniques for RapidArc Radiotherapy
    O'Daniel, J.
    McMahon, R.
    Chang, Z.
    Yan, H.
    Sakhalkar, H.
    Das, S.
    Wu, Q.
    Yin, F.
    MEDICAL PHYSICS, 2009, 36 (06)
  • [2] Evaluation of a Phantom for Patient-specific Quality Assurance in the MR Linac
    Baumgartl, M.
    Safarkhanlo, Y.
    Ehrbar, S.
    Wilke, L.
    Krayenbuhl, J.
    Chamberlain, M.
    Zamburlini, M.
    Guckenberger, M.
    Andratschke, N.
    Tanadini-Lang, S.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2021, 197 (SUPPL 1) : S33 - S34
  • [3] Development of pretreatment 'truly' patient-specific quality assurance procedure for stereotactic body radiotherapy using volumetric modulated arc radiotherapy
    Tachiiri, S.
    Tanaka, K.
    Tanaka, K.
    Yanagawa, M.
    Kosuga, T.
    Onishi, Y.
    Miyai, A.
    Otsu, S.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S229 - S229
  • [4] Dosimetric Validation for Patient-specific Quality Assurance using the Delta44 Phantom with Volumetric Modulated Arc Therapy
    Arino Gil, A.
    Calvo, O.
    Gutierrez, A.
    Papanikolau, N.
    Hdez-Armas, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S717 - S717
  • [5] Patient-Specific Quality Assurance Using a 3D-Printed Chest Phantom for Intraoperative Radiotherapy in Breast Cancer
    Choi, Yeonho
    Lee, Ik Jae
    Park, Kwangwoo
    Park, Kyung Ran
    Cho, Yeona
    Kim, Jun Won
    Lee, Ho
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [6] Feasibility of a 3D-printed anthropomorphic patient-specific head phantom for patient-specific quality assurance of intensity-modulated radiotherapy
    Yea, Ji Woon
    Park, Jae Won
    Kim, Sung Kyu
    Kim, Dong Youn
    Kim, Jae Gu
    Seo, Chan Young
    Jeong, Won Hyo
    Jeong, Man Youl
    Oh, Se An
    PLOS ONE, 2017, 12 (07):
  • [7] Quality assurance of micro-MLC based IMRT plans using patient-specific phantom
    Sunel, S.
    Yeginer, M.
    Akyol, F.
    Biltekin, F.
    Ozyigit, G.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S918 - S918
  • [8] Respiratory gated radiotherapy-pretreatment patient specific quality assurance
    Thiyagarajan, Rajesh
    Sinha, Sujit Nath
    Ravichandran, Ramamoorthy
    Samuvel, Kothandaraman
    Yadav, Girigesh
    Sigamani, Ashok Kumar
    Subramani, Vikraman
    Raj, N. Arunai Nambi
    JOURNAL OF MEDICAL PHYSICS, 2016, 41 (01) : 65 - 70
  • [9] Patient-specific radiotherapy quality assurance for estimating actual treatment dose
    Tanabe, Yoshinori
    Ishida, Takayuki
    Eto, Hidetoshi
    Sera, Tatsuhiro
    Emoto, Yuki
    Shimokawa, Mototsugu
    MEDICAL DOSIMETRY, 2021, 46 (01) : e5 - e10
  • [10] Deep Hybrid Learning Prediction of Patient-Specific Quality Assurance in Radiotherapy: Implementation in Clinical Routine
    Moreau, Noemie
    Bonnor, Laurine
    Jaudet, Cyril
    Lechippey, Laetitia
    Falzone, Nadia
    Batalla, Alain
    Bertaut, Cindy
    Corroyer-Dulmont, Aurelien
    DIAGNOSTICS, 2023, 13 (05)